LDDD
Longduoduo Company Limited
Price Chart
Latest Quote
$0.51
| Previous Close | $0.51 |
| Open | $0.93 |
| Day High | $0.93 |
| Day Low | $0.93 |
| Volume | 374 |
Stock Information
| Shares Outstanding | 30.02M |
| Total Debt | $68K |
| Cash Equivalents | $1.22M |
| Revenue | $2.13M |
| Net Income | $-353K |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $15.31M |
| EPS (TTM) | $-0.01 |
| Exchange | OID |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $14.21M |
| Sales | $2.13M |
| Income | $-353K |
| Book/sh | $0.03 |
| Cash/sh | $0.04 |
| Employees | 52 |
Financial Ratios
| Quick Ratio | 1.39 |
| Current Ratio | 1.54 |
| Debt/Eq | 8.55 |
Returns & Margins
| ROA | -14.24% |
| ROE | -43.13% |
| Gross Margin | 98.83% |
| Operating Margin | -105.36% |
| Profit Margin | -16.54% |
Ownership
| Insider Ownership | 67.66% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 7.18 |
| P/B | 20.40 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.51 |
| SMA50 | $0.51 |
| SMA200 | $0.75 |
| RSI | nan |
| Shares Float | 9.71M |
| Volatility | 1.20 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +0.00% |
| 6 Months | -14.04% |
| YTD | -14.04% |
| Year | -89.78% |
| 3 Years | -99.07% |
| 10 Years | -94.90% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $0.51 | 0 |
| 2026-06-23 | $0.51 | 0 |
| 2026-06-22 | $0.51 | 0 |
| 2026-06-18 | $0.51 | 0 |
| 2026-06-17 | $0.51 | 0 |
| 2026-06-16 | $0.51 | 0 |
| 2026-06-15 | $0.51 | 0 |
| 2026-06-12 | $0.51 | 0 |
| 2026-06-11 | $0.51 | 0 |
| 2026-06-10 | $0.51 | 0 |
| 2026-06-09 | $0.51 | 0 |
| 2026-06-08 | $0.51 | 0 |
| 2026-06-05 | $0.51 | 0 |
| 2026-06-04 | $0.51 | 0 |
| 2026-06-03 | $0.51 | 0 |
| 2026-06-02 | $0.51 | 0 |
| 2026-06-01 | $0.51 | 0 |
| 2026-05-29 | $0.51 | 0 |
| 2026-05-28 | $0.51 | 0 |
| 2026-05-27 | $0.51 | 0 |
| 2026-05-26 | $0.51 | 0 |
About Longduoduo Company Limited
Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers, product suppliers, and sales agents. It also provides meridian-regulating and consciousness restoring iatrotechnics; double blood purification; immunological ozonated autohemotherapy; platelet-rich plasma; relaxation therapy; vegetative nerve regulation; and microwave therapy. The company was founded in 2020 and is headquartered in Hohhot, China.
đ° Latest News
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $91,099 | $173,349 | $591,885 | $1,005,030 |
| Cost Of Revenue | $91,099 | $173,349 | $591,885 | $1,005,030 |
| Total Revenue | $4,262,663 | $7,389,842 | $3,818,560 | $3,237,993 |
| Operating Revenue | $120,866 | $327,599 | $1,808,515 | $3,223,124 |
| Expenses | ||||
| Total Expenses | $3,709,984 | $5,363,701 | $3,789,322 | $10,793,279 |
| Other Income Expense | $161,849 | $-139,656 | $2,093 | $-6,703 |
| Other Non Operating Income Expenses | $161,849 | $-139,656 | $2,093 | $-6,703 |
| Operating Expense | $3,618,885 | $5,190,352 | $3,197,437 | $9,788,249 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $460,435 | $1,255,448 | $-39,089 | $-7,517,365 |
| Normalized Income | $460,435 | $1,255,448 | $-39,089 | $-7,517,365 |
| Net Income From Continuing And Discontinued Operation | $460,435 | $1,255,448 | $-39,089 | $-7,517,365 |
| Total Operating Income As Reported | $552,679 | $2,026,141 | $29,238 | $-7,555,286 |
| Net Income Common Stockholders | $460,435 | $1,255,448 | $-39,089 | $-7,517,365 |
| Net Income | $460,435 | $1,255,448 | $-39,089 | $-7,517,365 |
| Net Income Including Noncontrolling Interests | $492,260 | $1,363,278 | $21,085 | $-7,563,565 |
| Net Income Continuous Operations | $492,260 | $1,363,278 | $21,085 | $-7,563,565 |
| Pretax Income | $714,528 | $1,886,485 | $31,331 | $-7,561,989 |
| Operating Income | $552,679 | $2,026,141 | $29,238 | $-7,555,286 |
| Gross Profit | $4,171,564 | $7,216,493 | $3,226,675 | $2,232,963 |
| Per Share | ||||
| Diluted EPS | $0.01 | $0.04 | $-0.00 | $-0.25 |
| Basic EPS | $0.01 | $0.04 | $-0.00 | $-0.25 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $689,969 | $2,128,173 | $96,976 | $-7,489,586 |
| Reconciled Depreciation | $137,290 | $102,032 | $67,738 | $65,700 |
| EBITDA (Bullshit earnings) | $689,969 | $2,128,173 | $96,976 | $-7,489,586 |
| EBIT | $552,679 | $2,026,141 | $29,238 | $-7,555,286 |
| Diluted Average Shares | $30,009,878 | $30,005,016 | $30,001,806 | $30,000,000 |
| Basic Average Shares | $30,009,878 | $30,005,016 | $30,001,806 | $30,000,000 |
| Diluted NI Availto Com Stockholders | $460,435 | $1,255,448 | $-39,089 | $-7,517,365 |
| Minority Interests | $-31,825 | $-107,830 | $-60,174 | $46,200 |
| Tax Provision | $222,268 | $523,207 | $10,246 | $1,576 |
| Selling General And Administration | $3,618,885 | $5,190,352 | $3,197,437 | $9,788,249 |
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,184,565 | $702,515 | $-545,785 | $-928,786 |
| Total Assets | $2,126,496 | $2,063,401 | $1,482,782 | $610,667 |
| Total Non Current Assets | $312,909 | $403,556 | $170,017 | $186,339 |
| Current Assets | $1,813,587 | $1,659,845 | $1,312,765 | $424,328 |
| Prepaid Assets | $133,610 | $124,427 | $68,341 | $33,837 |
| Receivables | $37,256 | $131,376 | $107,042 | $30,787 |
| Other Receivables | $37,256 | $131,376 | $107,042 | $30,787 |
| Cash Cash Equivalents And Short Term Investments | $1,642,721 | $1,404,042 | $1,136,562 | $356,672 |
| Cash And Cash Equivalents | $1,642,721 | $1,404,042 | $1,136,562 | $356,672 |
| Goodwill And Other Intangible Assets | - | $0 | $3,828 | $0 |
| Inventory | - | $0 | $820 | $3,032 |
| Debt | ||||
| Total Debt | $18,570 | $35,932 | $13,470 | $181,247 |
| Long Term Debt And Capital Lease Obligation | $0 | $18,314 | $6,891 | $2,986 |
| Current Debt And Capital Lease Obligation | $18,570 | $17,618 | $6,579 | $178,261 |
| Current Debt | - | - | - | $143,333 |
| Other Current Borrowings | - | - | - | $143,333 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $830,464 | $1,282,550 | $2,053,437 | $1,633,006 |
| Total Non Current Liabilities Net Minority Interest | $0 | $18,314 | $6,891 | $2,986 |
| Current Liabilities | $830,464 | $1,264,236 | $2,046,546 | $1,630,020 |
| Other Current Liabilities | $26,069 | $86,645 | $127,901 | $331,624 |
| Current Deferred Liabilities | $335,484 | $713,360 | $588,335 | $788,649 |
| Payables And Accrued Expenses | $450,341 | $446,613 | $1,323,731 | $331,486 |
| Payables | $400,314 | $396,506 | $1,232,873 | $205,532 |
| Accounts Payable | $399,906 | $358,613 | $1,044,247 | $40,812 |
| Other Payable | - | $35,660 | $84,015 | $90,162 |
| Equity | ||||
| Common Stock Equity | $1,184,565 | $702,515 | $-541,957 | $-928,786 |
| Total Equity Gross Minority Interest | $1,296,032 | $780,851 | $-570,655 | $-1,022,339 |
| Stockholders Equity | $1,184,565 | $702,515 | $-541,957 | $-928,786 |
| Gains Losses Not Affecting Retained Earnings | $77,028 | $55,413 | $66,389 | $24,971 |
| Other Equity Adjustments | $77,028 | $55,413 | $66,389 | $24,971 |
| Retained Earnings | $-6,169,197 | $-6,629,632 | $-7,885,080 | $-7,845,991 |
| Other | ||||
| Ordinary Shares Number | $30,015,036 | $30,005,016 | $30,005,008 | $30,000,000 |
| Share Issued | $30,015,036 | $30,005,016 | $30,005,008 | $30,000,000 |
| Tangible Book Value | $1,184,565 | $702,515 | $-545,785 | $-928,786 |
| Invested Capital | $1,184,565 | $702,515 | $-541,957 | $-785,453 |
| Working Capital | $983,123 | $395,609 | $-733,781 | $-1,205,692 |
| Capital Lease Obligations | $18,570 | $35,932 | $13,470 | $37,914 |
| Total Capitalization | $1,184,565 | $702,515 | $-541,957 | $-928,786 |
| Minority Interest | $111,467 | $78,336 | $-28,698 | $-93,553 |
| Additional Paid In Capital | $7,246,719 | $7,246,729 | $7,246,729 | $6,862,234 |
| Capital Stock | $30,015 | $30,005 | $30,005 | $30,000 |
| Common Stock | $30,015 | $30,005 | $30,005 | $30,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $18,314 | $6,891 | $2,986 |
| Current Deferred Revenue | $335,484 | $713,360 | $588,335 | $788,649 |
| Current Capital Lease Obligation | $18,570 | $17,618 | $6,579 | $34,928 |
| Current Accrued Expenses | $50,027 | $50,107 | $90,858 | $125,954 |
| Dueto Related Parties Current | $408 | $2,233 | $104,611 | $74,558 |
| Net PPE | $312,909 | $403,556 | $166,189 | $186,339 |
| Accumulated Depreciation | $-242,588 | $-148,582 | $-123,952 | $-65,786 |
| Gross PPE | $555,497 | $552,138 | $290,141 | $252,125 |
| Leases | $70,404 | $40,506 | $72,026 | $70,561 |
| Other Properties | $32,906 | $50,070 | $13,470 | $77,106 |
| Machinery Furniture Equipment | $452,187 | $461,562 | $204,645 | $104,458 |
| Properties | $0 | $0 | $0 | $0 |
| Duefrom Related Parties Current | - | - | - | $0 |
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $217,990 | $276,787 | $839,457 | $-83,310 |
| Operating Activities | ||||
| Operating Cash Flow | $277,365 | $582,282 | $965,337 | $28,572 |
| Cash Flow From Continuing Operating Activities | $277,365 | $582,282 | $965,337 | $28,572 |
| Operating Gains Losses | - | $10,070 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-59,375 | $-305,495 | $-125,880 | $-111,882 |
| Investing Cash Flow | $-59,375 | $-305,495 | $-125,880 | $-111,882 |
| Cash Flow From Continuing Investing Activities | $-59,375 | $-305,495 | $-125,880 | $-111,882 |
| Financing Activities | ||||
| Financing Cash Flow | $0 | $0 | $-143,333 | $179,697 |
| Cash Flow From Continuing Financing Activities | $0 | $0 | $-143,333 | $179,697 |
| Issuance Of Capital Stock | - | - | $0 | $30,982 |
| Net Common Stock Issuance | - | - | $0 | $30,982 |
| Common Stock Issuance | - | - | $0 | $30,982 |
| Other | ||||
| Issuance Of Debt | $0 | $0 | - | $148,715 |
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $231,580 | $523,207 | $10,246 | $1,576 |
| End Cash Position | $1,642,721 | $1,404,042 | $1,136,562 | $356,672 |
| Beginning Cash Position | $1,404,042 | $1,136,562 | $356,672 | $273,116 |
| Effect Of Exchange Rate Changes | $20,689 | $-9,307 | $83,766 | $-12,831 |
| Changes In Cash | $217,990 | $276,787 | $696,124 | $96,387 |
| Net Issuance Payments Of Debt | $0 | $0 | $-143,333 | $148,715 |
| Net Short Term Debt Issuance | $0 | $0 | $-143,333 | $148,715 |
| Short Term Debt Issuance | $0 | $0 | - | $148,715 |
| Net PPE Purchase And Sale | $-59,375 | $-305,495 | $-120,127 | $-111,882 |
| Purchase Of PPE | $-59,375 | $-305,495 | $-120,127 | $-111,882 |
| Change In Working Capital | $-396,540 | $-937,638 | $448,985 | $733,090 |
| Change In Other Working Capital | $-385,316 | $126,980 | $-145,760 | $376,867 |
| Change In Other Current Liabilities | $-61,383 | $13,965 | $73,731 | $-6,318 |
| Change In Payables And Accrued Expense | $-12,124 | $-880,060 | $972,513 | $62,473 |
| Change In Accrued Expense | $-776 | $-40,922 | $-32,595 | $12,545 |
| Change In Payable | $-11,348 | $-839,138 | $1,005,108 | $49,928 |
| Change In Account Payable | $36,036 | $-689,296 | $1,050,336 | $-137,841 |
| Change In Prepaid Assets | $-53,139 | $-169,635 | $-318,185 | $315,222 |
| Change In Inventory | $0 | $830 | $1,826 | $-3,358 |
| Change In Receivables | $115,422 | $-29,718 | $-135,140 | $-11,796 |
| Other Non Cash Items | $44,355 | $44,540 | $43,029 | $54,219 |
| Depreciation Amortization Depletion | $137,290 | $102,032 | $67,738 | $65,700 |
| Depreciation And Amortization | $137,290 | $102,032 | $67,738 | $65,700 |
| Depreciation | $137,290 | $102,032 | $67,738 | $65,700 |
| Gain Loss On Sale Of PPE | $0 | $10,070 | $0 | - |
| Net Income From Continuing Operations | $492,260 | $1,363,278 | $21,085 | $-7,563,565 |
| Repayment Of Debt | - | $0 | $-143,333 | - |
| Short Term Debt Payments | - | $0 | $-143,333 | - |
| Net Intangibles Purchase And Sale | - | $0 | $-5,753 | $0 |
| Purchase Of Intangibles | - | $0 | $-5,753 | $0 |
| Stock Based Compensation | - | $0 | $384,500 | $6,739,128 |